BOVICOR PHARMATECH INC has a total of 23 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are STONE ANDREW, ADVITOS GMBH and NAHEED SHABANA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Argentina | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Veterinary instruments or methods | |
#4 | Object sterilising | |
#5 | Therapeutic chemical compounds | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Miller Christopher C | 18 |
#2 | Regev-Shoshani Gilly | 16 |
#3 | Stenzler Alex | 12 |
#4 | Han Steve | 8 |
#5 | Gilly Regev-Shoshani | 5 |
#6 | Christopher C Miller | 5 |
#7 | Alex Stenzler | 4 |
#8 | Steve Han | 3 |
#9 | Owens Jane G | 1 |
#10 | Waln Randall L | 1 |
Publication | Filing date | Title |
---|---|---|
US2017151277A1 | Enhanced immune response in cattle upon treatment with nitric oxide | |
US2017128485A1 | Nitric oxide treatment of mammary tissue | |
US2016235512A1 | Animal intranasal administration device, systems, and associated methods | |
US2016082040A1 | Nitric oxide treatment of mammary tissue | |
CA2942841A1 | Nitric oxide treatment of bovine respiratory disease complex and other respiratory conditions | |
CA2930189A1 | Preparation and delivery of sustained nitric oxide releasing solutions |